% | $
Quotes you view appear here for quick access.

OncoGenex Pharmaceuticals, Inc. Message Board

  • jetmanbash jetmanbash Dec 31, 2010 10:32 AM Flag

    Competition update, MDVN:

    Medivation (MDVN) has appeared on our heightened volatility scan six times over the past few months. The co has ongoing Phase 3 HORIZON trial in Huntington disease and ongoing Phase 3 CONCERT trial in mild-to-moderate Alzheimer's disease patients taking donepezil. The co and Astellas announced last month that they completed enrollment in phase 3 affirm trial of MDV3100 in advanced prostate cancer on Nov 15 and plans to report top-line results from the HORIZON trial in 1H 2011.

0.3934+0.0184(+4.91%)2:45 PMEDT